Research programme: renin inhibitors 1100 series - Speedel
Alternative Names: SPP 1193; SPP-1100Latest Information Update: 14 Jul 2010
At a glance
- Originator Speedel Group
- Developer Speedel
- Class
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 14 Jul 2010 Discontinued - Preclinical for Hypertension in USA (PO)
- 10 Jul 2008 Speedel Group has been acquired by Novartis